IO Biotech chief accounting officer Burkavage resigns; CFO Sullivan to succeed

IO Biotech, Inc.

Brian Burkavage resigns as SVP and Chief Accounting Officer effective December 12, 2025 to pursue another opportunity; no dispute with company.
CFO Amy Sullivan designated as principal accounting officer upon Burkavage's departure; no new compensatory arrangements entered.
Sullivan's biography previously disclosed in IO Biotech's April 2025 definitive proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.